We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Micrima.
Micrima is a Bristol based diagnostic imaging company, developing a new Breast Imaging System (MARIA) aimed at radically improving breast cancer detection and survival rates through the provision of much safer, more frequent, more comfortable and less expensive breast checks from a much younger age, and delivered within the local community. The company’s proprietary technology seeks to improve screening effectiveness for both younger and older women with dense breast tissue, where X-ray mammography (XRM) is widely acknowledged to be inadequate.
